A new analysis underscores the burgeoning growth trajectory of the global Tourette Syndrome (TS) treatment market, which is poised for substantial expansion, with the US region being a key driver. Valued at USD 2,460.5 million in 2024, the market is projected to reach USD 3,685.5 million by 2032, exhibiting a robust Compound Annual Growth Rate (CAGR) of 5.26% over the forecast period, according...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt